ClinicalTrials.Veeva

Menu

An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia

Roche logo

Roche

Status

Completed

Conditions

Schizophrenia

Study type

Observational

Funder types

Industry

Identifiers

NCT01634542
MN28151

Details and patient eligibility

About

This multicenter, prospective, non-interventional study will evaluate the prevalence and characteristics of patients with persistent symptoms of schizophrenia and the course of their illness over 24 months.

Enrollment

1,433 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients:

  • Adult patients, >/= 18 years of age
  • Diagnosis of schizophrenia according to Diagnostic and Statistical Manual for Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) or International Classification of Diseases, 10th revision (ICD-10)

Caregivers:

  • Age >/= 18 years
  • Family member or friend of the patient, who spends at least 4 hours a week with the patient

Exclusion criteria

  • Acute psychotic exacerbation in the 3 months prior to the baseline observation (e.g. hospitalization or increased psychiatric care in order to prevent hospitalization)
  • Enrolled in an interventional study at the baseline observation

Trial design

1,433 participants in 1 patient group

Cohort

Trial contacts and locations

148

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems